JivaCare — Clinical Networks & Chronic Care

From reactive care to proactive health.

Empowering clinicians with continuous health insights that enable earlier intervention, better chronic disease management, and improved long-term outcomes.

SCROLL

01The Problem — Clinical Access

Care that ends at the clinic door.

A continuous blind spot between visits turns preventable chronic disease into catastrophic, late-stage admissions.

Snapshot Medicine

Doctors make life-changing decisions on a 10-minute consultation, while the other 525,590 minutes of a patient’s year remain largely invisible.

Chronic Disease Crisis · Kenya

NCDs account for 74% of all mortality globally. In Kenya they drive over 50% of hospital admissions and nearly 40% of all deaths.

Monitoring Blindness

A 14–21 day window before severe emergency hospitalization is invisible to insurers and doctors.

Chronic Disease Crisis · US

119M US adults carry chronic illnesses, with exploding growth in metabolic syndromes globally.

The African Data Blind Spot

Africa is 17% of the global population yet under 2% of clinical and genomic datasets. No continuous biometric dataset exists for Sub-Saharan populations.

Geographic Access

Doctor-to-patient ratios exceeding 1:16,000 in some regions leave rural and peri-urban populations highly vulnerable.

01.1Everyone wins when care is continuous

ClinicianFlying blind between visits — only snapshots.Continuous VisibilityReal-time telemetry and predictive clinical reports between appointments.
PatientReactive, late-stage acute admissions.Proactive CareAnomalies caught weeks before an ED visit.
Clinic operatorNo recurring revenue; high churn.Recurring RevenueHigh-margin subscription resale and deepened retention.

Continuous. Proactive. Connected.

02Why JivaCare · Why Now

A chronic-care market tripling under our feet.

Two of the world’s largest underserved chronic-management markets — reachable today through provider networks, telemedicine and BLE telemetry.

Africa — Chronic Management

1:16,000

critical access gap — extreme rural doctor-to-patient ratios.

54.4%

reside in rural access gaps that continuous telemetry & telemedicine bypass.

4.5M+

chronic patient base — adults living with an active NCD in Kenya.

$424.5M

MEA Chronic Disease Management market, projected to nearly triple to $1.18B by 2033 at a CAGR of 13.7%.

35.8%

African out-of-pocket spending validating the value-driven model.

$259B

Africa healthcare market projected by 2030.

over 50%

of all hospital admissions driven by chronic disease & NCDs.

India — Chronic Management

1:811

rural physician access gap.

69.7%

reside in rural access gaps bypassed by cellular & BLE telemetry.

400M+

people living with chronic conditions (400–450M range).

$689M

Indian chronic care market projected to double to $1.42B by 2032 at CAGR ~11%.

62%

out-of-pocket health spend validating direct provider-led entry.

$29.6B+

Indian care-services market growing at ~13.8% CAGR through 2030.

02.1Four structural forces, converging at once

Telemedicine + BLE Telemetry

Bypassing Physical Isolation

Continuous monitoring and telemedicine reach rural populations physical clinics cannot.

Hardware Economics

Cheaper Than a Single Visit

The bill of materials for medical-grade telemetry now costs less than one clinic visit.

Chronic Disease Market Growth

Tripling Demand

MEA chronic-management markets nearly triple by 2033; India doubles by 2032.

Provider-Network GTM

Turn-Key Clinic Revenue

Distributed only through provider networks — recurring revenue, retention, predictive care. No insurer partnership required.

03The Platform

Three layers, one continuous loop.

The same telemetry pipeline, surfaced as clinic dashboards — Rx adherence, telemedicine workflows and continuous risk, in one place.

LAYER 01

Data Collection

The JIVA Band (24/7 telemetry), biannual Mobile Health Units, clinical records and partner feeds — integrated via direct uploads or in-app scans.

LAYER 02

App & Storage

Historical data, behavioral habits, prescriptions and past consultations. Tailored clinic dashboards with integrated identity verification.

LAYER 03

AI Diagnostics

A continuously-updating risk profile. JIVA AI acts as a bias-reducing diagnostic layer ingested from clinic streams, streamlining telemedicine and Rx adherence.

04Operations & Revenue

Clinic-led distribution, recurring revenue.

Patient vitals sync straight to clinical dashboards — turning continuous monitoring into recurring clinic revenue.

$0 / user / mo

Flat wholesale subscription — clinics set their own retail margin.

Clinics keep the markup

High-margin recurring cash revenue from the existing patient base.

04.1The Clinic Value Loop

ClinicResells subscription
JIVA$8 wholesale + AI
PatientWears the band

Continuous telemetry flows back as retained patients and recurring revenue — a loop that rewards staying connected.

05Clinical Use Cases

From chronic management to acute recovery.

Chronic Management

  • Between-visit monitoring
  • Rx adherence loops
  • High-risk cohort management
  • Telemedicine audit of AI risk data

Acute Recovery

  • Bands prescribed post-discharge
  • Readmission prevention
  • Real-time post-discharge stability
  • The doctor’s decision loop

05.1The Acute Care Opportunity

20.8%

Africa readmission risk.

9M

Africa annual acute admissions.

16.2%

India readmission risk.

14M

India annual acute admissions.

Acute Care Market Cap · USD Billion · 2026 → 2032

India12.8% CAGR
$4.2B
2026
$11.1B
2032
Africa11.2% CAGR
$3.1B
2026
$6.5B
2032

05.2The Doctor’s Decision Loop

01

Prescribe the Band

A clinician prescribes the JIVA Band for chronic or post-discharge acute recovery.

02

Real-Time Stability

Continuous post-discharge telemetry surfaces autonomic anomalies as they emerge.

03

Proactive Intervention

The clinician acts before emergency readmission triggers — a telemedicine check-in, an Rx change.

04

Better Outcomes

Readmissions prevented; the diagnostic model sharpens with every loop.

“Clinicians prescribe JIVA bands for acute recovery to gain real-time visibility into post-discharge stability, allowing proactive intervention before emergency readmission triggers.”

06Hardware & Data

A medical instrument — not a wellness toy.

The JIVA Band — a medical-grade biometric wearable

The JIVA Band

CSS W10
  • 256 Hz medical-grade ECG electrodes
  • Dual-wave PPG biosensor
  • Skin thermistor (temperature)
  • 3D accelerometer + gyroscope (motion)
  • Ambient light sensor
  • IP68 ingress protection
  • AES-256 encryption at rest & in transit
FCCCE / REDRoHSSRRCFDA — on roadmap

Mobile Health Unit

72-test sweep

Bi-annual 72-test sweeps deliver absolute identity verification and baseline calibration.

  • Biochemistry lab
  • Digital X-Ray
  • Pulmonary function
  • Audiometry
  • Fundus camera
  • OBG / cardiac-specific diagnostics

07The Markets

From Nairobi clinics to emerging-market scale.

Kenya & East Africa clinical networks → India rural access → emerging markets.

07.1The Roadmap

Phase 01 · 2026 → Q2 2027

Kenya Operations

  • • Scale the STAR pilot: 100 → 18,000 → entire network
  • • Deploy Mobile Health Units
  • • Secure hospital data for ML training

Phase 02 · Q3 2027

East Africa & India

  • • East Africa pipelines
  • • Indian market entry
  • • Scaled, demographic-specific AI training

Phase 03 · End 2027

US Market Launch

  • • Launch US healthcare diagnostic tool
  • • Capture CMS RPM billing pools
  • • Licensing & compliance — FDA, CE, HIPAA

08The Team

Theoretical and practical — in equal measure.

Stanford

Shlok Saini

Co-Founder & CEO

Management Science & Engineering + Economics

Healthcare and insurance exposure through family; deep background in math and quantitative analysis. Indian-market understanding through Bliss GVS Pharma.

Stanford

Arjun Prakash

Co-Founder & COO

Economics + Human Biology

Blends sport physiology with hands-on operational execution, having launched his own sports complex in Calcutta. Deep marketing and large-scale HR management from a family footprint in hospitality and tea.

Stanford

Agastya Bhartia

Co-Founder

Biomedical Computation + Bio Engineering

Life sciences (Jubilant Bhartia) and marketing/media (Hindustan Times) experience. Coordinates global life-sciences architecture and AI strategy.

08.1Leadership & Directors

JivaCare’s clinical decisioning is led by Dr. Deepak Kumar (CHO), anchoring every workflow in front-line intensive-care experience.

Dr. Deepak Kumar

Clinical Director · CHO

Two decades as an intensive-care resident across Indian and Kenyan capital cities, guiding JIVA’s clinical decision-making.

Ramdev Krishnan

Full-Time Director · CTO

Project Head on the ground. Ex-Tata Communications senior leader. Directed 10,000+ MHUs across regional markets.

Ali Abbas Jaipuri

Procurement Director

25+ years of healthcare and medical-equipment executive experience, sourcing and operational integration across East Africa.

Asif Ali Ansari

Full-Time Director

Worked at Apeiro which, with Sirius IHC, developed the government health scheme software. Strategic institutional-network lead.

09Partner — For Clinical Networks

Partner with JivaCare.

Join the JIVA Network.

Deploy a 180-day cohort pilot — JIVA manages hardware, training and onboarding.

JIVA Technologies Limited · Palo Alto, CA 94301